Skip to main content
logo
Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
1.160
-0.010 (-0.85%)
At close: Sep 3, 2026, 4:00 PM EDT
1.160
0.00 (0.00%)
After-hours: Sep 3, 2026, 4:00 PM EDT

Indaptus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
153510151247
Market Cap Growth
2030.04%-49.63%-31.58%21.38%-73.92%-
Enterprise Value
142-13-1-165
Last Close Price
1.172.9123.5849.2840.60159.60

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
13.711.622.571.220.501.30
P/TBV Ratio
13.561.622.571.220.501.30

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
--0.020.010.000.01
Net Debt / Equity Ratio
-1.02-2.70-1.45-1.09-1.07-1.08
Net Debt / EBITDA Ratio
-0.430.370.811.775.04
Net Debt / FCF Ratio
0.790.570.460.982.023.45
Quick Ratio
18.771.381.714.827.708.50
Current Ratio
19.481.511.955.057.948.77
Return on Equity (ROE)
-318.04%-587.59%-187.53%-84.04%-47.32%-43.25%
Return on Assets (ROA)
-98.08%-148.91%-86.28%-47.63%-27.15%-22.81%
Return on Capital Employed (ROCE)
-129.90%-629.30%-389.50%-134.80%-60.50%-21.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-10.00%-409.13%-148.48%-104.31%-117.58%-16.51%
FCF Yield
-9.53%-290.89%-121.81%-90.66%-107.36%-24.18%
Buyback Yield / Dilution
-7142.37%-189.14%-11.36%-1.68%-101.98%-110.35%
SEC Filings: 10-K · 10-Q